無復發腫瘤 的英文怎麼說
中文拼音 [wúfùfāzhǒngliú]
無復發腫瘤
英文
negative for recurrent neoplasm-
A pathological examination proved the lesion to be carcinoma in situ of the conjunctiva with invasion into cornea
在10個月追蹤過程中，腫瘤自行消退，無復發現象。After treatment, 5 patients achieved complete remission : among with, one died of chemotherapy complication, one died of intercurrent disease, one had distant metastasis, and only 2 patients remained disease free
治療后， 5位病患的腫瘤完全緩解，爾后其中1位死於化療之副作用， 1位死於其他疾病， 1位轉移，只有2位至今無疾病復發跡象。Studies of the crystal structure of endostatin have shown a compact globular fold, with one face particularly rich in arginine residues acting as a heparin - binding epitope, this site was recently shown to be involved in the inhibition of induced angiogenesis. experimental studies show that recombinant endostatin specifically inhibits the proliferation of endothelial cells in a dosedependent fashion. recombinant endostatin from bacteria is largely insoluble, but still efficient in arresting tu mor growth after injection into mice. intermittent therapy with recombinant bacterially produced endostatin reduces several experimental tumors, including lewis lung carcinoma, to a dormant state. no sign of drug induced resistance has been reported and, in the original study, the treatment dormancy appeared to persist even when therapy was discontinued. sowe regard endostatin as a promising anti - tumor drug
許多研究表明重組內皮抑素特異性抑制內皮細胞增殖，而且這種抑制作用呈劑量依賴性。細菌表達產物內皮抑素大部分以不溶形式存在，將這種混懸液注射治療老鼠仍可以抑制腫瘤生長。于小鼠皮下重復注射內皮抑素重組蛋白，幾乎完全抑制鼠lewis肺癌等多種腫瘤生長，並無耐藥性產生，即使中斷治療腫瘤也不再復發。Results : there was no recurrence or tumor metastasis at a mean flow - up of 10 months
結果：本組術后無外科並發癥，平均隨訪10個月，無局部復發和腫瘤轉移。It has been suggested that patients with hepatocellular carcinoma ( hcc ) undergoing living donor liver transplantation ( ldlt ) have worse recurrence - free survival compared to deceased donor liver transplantation ( clt ), leading to the hypothesis that short waitlist time or fast - tracking may include more aggressive tumors that would have been selected out by traditionally longer waitlist time
因有已經提議認為肝細胞癌的患者，接受活體供體肝移植的相對于屍體供體肝移植而言，有更壞的存活期無復發率（即更快的移植后復發率） ，導致了認為可能包括更有侵襲性的腫瘤的患者應該在傳統的長時間等待名單上被挑選出來，以短暫等待時間或者快速示蹤（的方式盡快接受肝移植的）假說。Results almost all cases investigated resulted in satisfactory outcomes
保留的殘余腺體有涎液分泌，腫瘤無復發。No matter the doctor of traditional chinese medicine still is western medicine, in the light of tumor patient operation hind has food of certain avoid certain food, come to those who raise art hind turn curative effect fruit with this, and precaution has a relapse, want excuse me the expert of this respect, or personage of the major that has research to this respect, blame major
無論中醫還是西醫，針對腫瘤病人手術后都有一定的忌口食物，以此來提高術后的化療效果，以及預防復發，想請問一下這方面的專家，或對這方面有研究的專業、非專業人士。分享友人